DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

0.97 0.08 (8.99%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMUC $0.97 8.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.01
Previous Close $0.89
Daily Range $0.95 - $1.02
52-Week Range $0.65 - $4.00
Market Cap $58.8M
P/E Ratio -5.93
Dividend (Yield) $0.00 (0.0%)
Volume 1,596,795
Average Daily Volume 263,138
Current FY EPS -$0.24

Sector

Healthcare

Industry

Healthcare Information Services

ImmunoCellular Therapeutics, Ltd. (IMUC) Description

ImmunoCellular Therapeutics, Ltd. Website: http://www.imuc.com/

News & Commentary Rss Feed

3 Possible Catalysts for Inovio Pharmaceuticals in 2014

Inovio Pharmaceuticals could be a stock to watch in 2014 for these three reasons.

ImmunoCellular: Thoughts On Management's Plan To Move ICT-107 Into Phase 3

5 Companies Developing New Cancer Drugs

ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q2 2014 Results - Earnings Call Transcript

Wednesday Sector Laggards: Drugs, Biotechnology Stocks

Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer

Positive Trends For ImmunoCellular Therapeutics

Twelve Analyst Stocks to Buy Under $10 With Huge Implied Upside

Monday Sector Laggards: Drugs, Manufacturing Stocks

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis P

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunothe

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunotherapeutic Vaccine

See More IMUC News...

IMUC's Top Competitors

IMUC $0.97 (8.99%)
Current stock: IMUC
JNJ $106.19 (0.29%)
Current stock: JNJ
NVS $94.72 (0.36%)
Current stock: NVS
RHHBY $37.37 (-0.31%)
Current stock: RHHBY